Evidence for IGF/IGF-1R signaling conferring lenvatinib resistance in HCC still has not been investigated; however, some IGF/IGF-1R-crosstalked signaling have been found to be involved in lenvatinib resistance. This evidence concerns the gene IGF1 and hepatocellular carcinoma.